Link to this page
Medical Subject Headings
Last uploaded:
March 22, 2026
| Id | http://purl.bioontology.org/ontology/MESH/C524459
http://purl.bioontology.org/ontology/MESH/C524459
|
|---|---|
| Preferred Name | rilotumumab |
| Synonyms |
AMG102
AMG 102
AMG-102
|
| Type | http://www.w3.org/2002/07/owl#Class |
All Properties
| altLabel |
AMG102
AMG 102
AMG-102
|
|---|---|
| prefLabel | rilotumumab
|
| Scope Statement | a fully human monoclonal antibody that binds to hepatocyte growth factor (HGF), a potential cancer therapeutic agent because of its ability to disrupt HGF/c-Met signaling pathways which have been implicated in most tumor types
|
| type | |
| isa | |
| PA | D000074322
|
| tui |
T116
T129
T121
|
| HM | D061067
|
| SC | 1
|
| TERMUI |
T760430
T760429
T760428
T760427
|
| TH |
NLM (2009)
FDA SRS (2017)
USAN (19XX)
INN (19XX)
|
| SRC | Pharm Res 2007 Oct;24(10):1910-8
|
| MMR | 20191101
|
| notation | C524459
|
| Semantic type UMLS property | |
| cui |
C1879711
C2743963
|
| MeSH Frequency | 42
|
| DSC | 20071126
|
| Inverse of RB | 51WEW898IJ
|
| Mapped to | |
| MDA | 20071126
|
| Delete | Subject | Author | Type | Created |
|---|---|---|---|---|
| No notes to display |